Eli Lilly and Company
Science into healing for chronic disease
Indianapolis, Indiana, United States
Eli Lilly and Company is a global healthcare leader specializing in the discovery, development, manufacturing, and marketing of innovative pharmaceutical products. Headquartered in Indianapolis, Indiana, it focuses on addressing unmet medical needs across various therapeutic areas.
How We Help
Core Technology
drug discovery systems, foundation models for biology and chemistry, manufacturing AI
Key Differentiators
Continuous, heavy investment in R&D, therapeutic specialization in high-growth areas (e.g., diabetes, oncology), significant expansion of manufacturing capacity, strong intellectual property and patent portfolio, strategic collaborations, and integration of AI across operations.
Clinical Focus
COVID-19 treatment
Target Customers
Healthcare providers, hospitals, pharmacies, and indirectly, patients. Also veterinarians/farmers for animal health products.
Product Stage
Mature
Company Info
- Business Model
- B2B/B2C Pharmaceutical; revenue generated through product sales, collaboration and licensing agreements, and animal health product sales.
- Founded
- 1876
- Website
- lilly.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FDA approved: Mounjaro (diabetes/obesity), Zepbound (obesity), Kisunla (early Alzheimer's), Omvoh (IBD). Phase 3 trials completed: tirzepatide 22.5% weight loss (SURMOUNT-1), donanemab 35% decline slowdown (TRAILBLAZER-2), orforglipron pending April 2026 PDUFA. Published in NEJM. Real-world evidence programs: TROPHIES, EMPRISE
IP Protection
Strong intellectual property and patent portfolio.
MedStartr Index Score
?What do you think of Eli Lilly and Company?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.